Silo Wellness (XCNQ:SILO) Debt-to-Equity : -0.48 (As of Jul. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Silo Wellness Debt-to-Equity?

Silo Wellness's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2023 was C$1.11 Mil. Silo Wellness's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2023 was C$0.00 Mil. Silo Wellness's Total Stockholders Equity for the quarter that ended in Jul. 2023 was C$-2.33 Mil. Silo Wellness's debt to equity for the quarter that ended in Jul. 2023 was -0.47.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Silo Wellness's Debt-to-Equity or its related term are showing as below:

XCNQ:SILO' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.79 Med: -0.19 Max: 0.08
Current: -0.48

During the past 3 years, the highest Debt-to-Equity Ratio of Silo Wellness was 0.08. The lowest was -2.79. And the median was -0.19.

XCNQ:SILO's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.29 vs XCNQ:SILO: -0.48

Silo Wellness Debt-to-Equity Historical Data

The historical data trend for Silo Wellness's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silo Wellness Debt-to-Equity Chart

Silo Wellness Annual Data

Trend

Oct20

Oct21

Oct22

Debt-to-Equity

-2.79

-0.16

-0.01

Silo Wellness Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Debt-to-Equity	Get a 7-Day Free Trial										-0.59	-0.01	-0.15	-0.52	-0.48

Competitive Comparison of Silo Wellness's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Silo Wellness's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Silo Wellness's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Silo Wellness's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Silo Wellness's Debt-to-Equity falls into.

Silo Wellness Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Silo Wellness's Debt to Equity Ratio for the fiscal year that ended in Oct. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.045	+	0)	/	-7.261
	=	-0.01

Silo Wellness's Debt to Equity Ratio for the quarter that ended in Jul. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.106	+	0)	/	-2.33
	=	-0.47

Silo Wellness (XCNQ:SILO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Silo Wellness Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Silo Wellness's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Silo Wellness (XCNQ:SILO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silo Wellness Inc (XCNQ:SILO) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Consumers Road, Suite 702, Toronto, ON, CAN, M2J 4R4

Website

https://www.silowellness.com

Silo Wellness Inc operates psychedelic clinics and develops legal functional mushroom consumer products. It is focused on health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.

Executives

Michael Hartman

Director